Literature DB >> 21489416

The relationship between cognitive insight, clinical insight, and depression in patients with schizophrenia.

Okan Ekinci1, Görkem Karakas Ugurlu, Yakup Albayrak, Murat Arslan, Ali Caykoylu.   

Abstract

Despite comorbid depression being relatively common even in subjects with schizophrenia, to the best of our knowledge, there is, to date, no report in the literature specifically and detailed examining the cognitive and clinical insight in subjects with schizophrenia and a comorbid depressive syndrome. Hence, in this study, we sought to compare the cognitive and clinical insight in our subjects with schizophrenia with and without a comorbid depressive syndrome. We found that participants in the depressive group scored significantly higher on self-reflectiveness and the reflectiveness-certainty (R-C) index scores than those in the nondepressive group. There was no significant difference among groups on the Scale for the Assessment of Positive Symptoms, Scale for the Assessment of Negative Symptoms, and clinical insight scores assessed by the Scale to Assess Unawareness of Mental Disorder. In addition, self-reflectiveness scores significantly correlated with depression, observed depression, hopelessness, and suicidality subscores of the Calgary Depression Scale for Schizophrenia. A better understanding of the cognitive component of insight in schizophrenia with comorbid depression may contribute to develop more efficient cognitive strategies, thus improving patient outcome. However, clinicians should be aware of the possibility of exacerbating a sense of hopelessness and suicide risk during the interventions that improve cognitive insight.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21489416     DOI: 10.1016/j.comppsych.2011.02.010

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  6 in total

1.  Lifetime suicide intent, executive function and insight in schizophrenia and schizoaffective disorders.

Authors:  Deepak Verma; M K Srivastava; Sunil K Singh; Triptish Bhatia; Smita N Deshpande
Journal:  Schizophr Res       Date:  2016-08-29       Impact factor: 4.939

2.  Association Between NR4A2 Gene Polymorphism and Depressive Symptoms and Antidepressant Effect.

Authors:  Xiaotong Song; Ning Sun; Aixia Zhang; Lei Lei; Xinrong Li; Zhifen Liu; Yanfang Wang; Chunxia Yang; Kerang Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-08-10       Impact factor: 2.570

Review 3.  Systematic review reveals heterogeneity in the use of the Scale to Assess Unawareness of Mental Disorder (SUMD).

Authors:  Rémy Dumas; Karine Baumstarck; Pierre Michel; Christophe Lançon; Pascal Auquier; Laurent Boyer
Journal:  Curr Psychiatry Rep       Date:  2013-06       Impact factor: 5.285

4.  Assessing cognitive insight in nonpsychiatric individuals and outpatients with schizophrenia in Taiwan: an investigation using the Beck Cognitive Insight Scale.

Authors:  Yu-Chen Kao; Tzong-Shi Wang; Chien-Wen Lu; Yia-Ping Liu
Journal:  BMC Psychiatry       Date:  2011-10-21       Impact factor: 3.630

5.  Co-occurring Deficits in Clinical and Cognitive Insight in Prolonged Schizophrenia-Spectrum Disorders: Relationship to Metacognitive Deficits.

Authors:  Joshua E Mervis; Kelsey A Bonfils; Samuel E Cooper; Courtney Wiesepape; Paul H Lysaker
Journal:  Schizophr Bull Open       Date:  2021-07-20

6.  Psychometric Properties of the Insight in Psychosis Questionnaire and its Correlation to Psychopathology in Indian Population.

Authors:  Rohit Garg; Satinder Kaur Cheema; Rajnish Raj
Journal:  Indian J Psychol Med       Date:  2018 Mar-Apr
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.